GLP-1 receptor agonists are widely used for diabetes and obesity and may be associated with a lower incidence of some obesity-related cancers, though evidence remains largely observational. Current ...

Researchers have been discovering new health benefits of the drugs used to treat diabetes and obesity.

GLP-1 medications have exploded in popularity over the past few years, and it's easy to see why. They work. People lose significant weight, blood sugar improves, and for the first time in a long ...

GLP-1 receptor agonists were associated with a 41% lower risk of obesity-related cancers in patients with obesity but without diabetes, according to a new propensity-matched cohort study published ...